CA
NZ
UK
AU
IND
US
Avantor, Inc. announced net sales of $1.692 billion for the second quarter of 2026, exceeding the consensus estimate of $0.19 with adjusted EPS of $0.21. The improved performance signals positive momentum for the company's growth strategy amid a challenging macroeconomic environment.Key HighlightsNet sales reached …
Beta Bionics (NASDAQ: BBNX) posted second‑quarter net sales of $32.0 million, a 38% increase from the comparable period last year, while earnings per share came in at $‑0.53 versus a consensus estimate of $‑0.61. The earnings beat underscores the company’s accelerating top‑line momentum despite …
Hims and Hers has seen its shares decline by 10% in response to a lawsuit filed by the Federal Trade Commission (FTC) concerning the company's data-sharing and billing practices. The FTC raises serious allegations, including claims that the company improperly shared health data with …
HCA Healthcare (NYSE: HCA) has doubled its unsecured commercial paper capacity, lifting the aggregate limit from $4.0 B to $8.0 B. The expanded program gives the company a wider runway for short‑term cash requirements, and the parent guarantor continues to back the notes unconditionally. …
Humana Inc. (NYSE: HUM) reported a strong EPS of $7.61 for the quarter ending June 30, 2026, surpassing analysts' consensus estimate of $7.29. This performance demonstrates effective cost management amid the ongoing challenges of inflation in medical expenses. However, despite the earnings beat, investors …
Acadia Healthcare's net profit for the second quarter of 2026 decreased 64% year-over-year to $10.9 million, impacting investor sentiment. Despite this decline, the company raised its full-year outlook and affirmed its growth strategy, signaling potential resilience amid challenges.Key HighlightsAcadia Healthcare's Q2 2026 net profit …
Align Technology, Inc. (NASDAQ: ALGN) has announced a significant increase in its share repurchase commitment, now set at a range of $400 million to $500 million for 2026. This action comes amid a broader strategy to bolster corporate governance and operational efficiency, reflecting the …
Anika Therapeutics (NASDAQ: ANIK) delivered a standout second‑quarter performance, posting earnings per share that exceeded market consensus. Revenue rose to $32.6 million, outpacing the prior‑year total of $28.2 million, while commercial channel sales surged 17% to a record $13.9 million. The company also posted …
CONMED Corp (NYSE: CNMD) delivered an adjusted earnings per share (EPS) of $1.38 for the second quarter, greatly surpassing the consensus estimate of $1.13. This solid performance, coupled with strategic operational changes, positions the company favorably for long-term growth, as reflected in its shares …
Bausch Health Companies Inc. demonstrated strong financial performance in its Q2 2026 earnings report released on July 29, 2026. The company achieved a substantial earnings per share (EPS) of $1.26, outperforming the consensus estimate of $1.05, thus signaling a positive quarter for investors. Meanwhile, …
Please wait processing your request...